This message contains images. If you don't see images, click here to view.
Advertise in this news brief.
|
|
|
|
Join us at the 41st Annual Symposium Convention in Washington, DC
NSH
Join NSH and your fellow Histotechnicians at the NSH Annual Symposium/Convention (S/C) Aug. 28 - Sept. 2. The S/C is the largest educational event of its kind for the histology profession. Whether you attend the full five educational-packed days of workshops or are only able to attend on the weekend, customize a schedule that fits your time out of the lab and meets your educational and budget needs at the same time.
A weekend of workshops will cost only $245 and you will receive 10.5 CE credits. It is possible to earn a certificate of completion in one of the areas in a weekend. NSH offers a certificate of completion for Immunohistochemistry, Molecular, Management and Safety. These certificates will provide you with practical, applicable skill documentation that can be used to enhance your marketability both within and outside your organization. Only nine CE credits are required in one of the three areas. Register now.
|
|
Share this article:
    |
|
|
Call for NSH mentors at the 41st Annual Symposium Convention
NSH
Do you remember what it was like starting out in the Histology field and the first time you attended the NSH Symposium/Convention?
Are you looking for a way to get involved?
Do you enjoy sharing your knowledge with others?
Are you attending this year's NSH Symposium/Convention in Washington, D.C.?
If your answers are yes, then your help is needed now. We are looking for NSH Symposium/Convention mentors, and you fit who we are looking for. Sign up now to be an NSH Symposium/Convention mentor by clicking here.
Then, two weeks prior to the S/C, Brenda from NSH will email you a list of first-time attendees (currently there are 119 first-time attendees registered) and ask you to reach out via email or phone to set up a time and place to meet with them at the Symposium/Convention. You are also welcome to come to the First Time Attendee reception on Friday night to meet up with them there. Your mentoring will help the first-time attendee navigate through the whole NSH experience. Checking in with them periodically, maybe inviting them to dinner or lunch, meeting them at the continental breakfast, taking them around the exhibit hall a little and teaching them to network.
If this is something you would be interested, please sign up today. Mentors will also get two free contact hours for volunteering. Contact Brenda@nsh.org with any questions.
PRODUCT SHOWCASE
 |
|
GBI Labs produces the largest selection of secondary detection kits, from single to multiple detection kits, with wide range host species.
We provide FREE samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market with 20%-30% cost less.
|
|
How Ebola-vaccine success could reshape clinical-trial policy
Nature
When Ebola broke out in West Africa in December 2013, triggering the largest-ever epidemic of the disease, there was no vaccine or drug that had been shown to be safe and effective in people. Just 20 months later, a vaccine seems to confer total protection against infection, according to the preliminary results of a trial in Guinea that were published July 31. Nature looks at the implications of the trial's success for the ongoing epidemic, which has killed more than 11,000 people, as well as for how future clinical trials are conducted in outbreaks.
Mitochondrial disease research makes progress
The Wall Street Journal
Scientists have made significant advances in the quest to treat mitochondrial disease, an incurable genetic malady that afflicts thousands of United States children each year.
In experiments reported recently in the journal Nature, researchers used two cutting-edge laboratory techniques — cloning and cell reprogramming — to make fresh tissue that was a perfect genetic match for patients suffering from the disorder.
Cures Act would ramp up funding for disease research
WRAL-TV
 Federal funding for medical research flatlined more than 10 years ago.
Now, there's hope that will change and ramp up the fight against cancer and other series diseases.
The 21st Century Cures Act promises $8.5 billion over five years. It recently passed the House and is now awaiting debate in the Senate.
|
Missed an issue of Under The Microscope? Click here to visit the Under The Microscope archive page.
|
Fast, accurate genetic tests may soon help doctors tell if you really need antibiotics
Duke University via Medical Xpress
Duke students are trying to help doctors find a faster way to pinpoint the cause of their patients' coughs, sore throats and sniffles. The goal is to better determine if and when to give antibiotics in order to stem the rise of drug-resistant superbugs, said senior Kelsey Sumner.
For 10 weeks this summer, Sumner and fellow Duke student Christopher Hong teamed up with researchers at Duke Medicine to identify blood markers that could be used to tell whether what's making someone sick is a bacteria or a virus.
PRODUCT SHOWCASE
 |
|
Avantik Biogroup is proud to introduce another Customer Requested Quality Innovation for Histology...the Avantik Biogroup Block Storage Cabinet! We introduced Hassle-Free Drawer Technology with Interlocking Stackability and More Clearance between the top of the blocks and the drawers to achieve the industry's first Jam-Free, Hassle-Free Block Storage Cabinet!
|
|
Clinical labs air concerns regarding FDA's draft LDT guidance
Genome Web
Clinical laboratory managers aired their concerns during the American Association for Clinical Chemistry meeting regarding the draft guidance issued last fall by the U.S. Food and Drug Administration on how it plans to regulate lab-developed tests.
They are particularly worried about how to define what is and what is not a lab-developed test as well as the time and expense of taking an LDT through the FDA clearance or approval process, and how such regulations may affect patient care. In addition, they are concerned about how any overlap between FDA and Centers for Medicare and Medicaid Services regulations would be handled.
Neuroblastoma cancer cells weaken immune system 'like kryptonite'
Medical News Today
A new molecule found in the cancer cells of neuroblastoma — a rare cancer that primarily affects young children — holds the key to developing an effective treatment for the disease, according to a new study published in Cancer Research.
Researchers create smartphone-based device that reads medical diagnostic tests quickly and accurately
Bioscience Technology
Enzyme-linked immunosorbant assay, or ELISA, is a diagnostic tool that identifies antigens such as viruses and bacteria in blood samples. ELISA can detect a number of diseases, including HIV, West Nile virus and hepatitis B, and it is widely used in hospitals. It can also be used to identify potential allergens in food, among other applications.
A team of researchers from the California NanoSystems Institute at UCLA has developed a new mobile phone-based device that can read ELISA plates in the field with the same level of accuracy as the large machines normally found in clinical laboratories.
Source data verification: A quality control measure in clinical trials
Clinical Leader
In an industry that seems to be focused on cutting the cost of clinical trials, it's no surprise that reducing the amount of source data verification performed in studies — the process of cross-referencing data recorded in a case-report form to the original source information — is an integral part of risk-based monitoring strategies. Eliminating source data checks that do not add value to the study is certainly a breakthrough for trials where we have historically performed 100 percent data verification. After all, why verify data that we already know to be correct, and is a low risk to the study as well?
Computer algorithm can forecast patients' deadly sepsis
Johns Hopkins University via Medical Xpress
For a patient with sepsis — which kills more Americans every year than AIDS and breast and prostate cancer combined — hours can make the difference between life and death. The quest for early diagnosis of this life-threatening condition now takes a step forward, as Johns Hopkins University researchers report on a more effective way to spot hospital patients at risk of septic shock.
Apple designs new App to allow use of iPhones to recruit, track patients in clinical study
Dark Daily
By providing tools to allow users to be more productive in working with healthcare big data, several Silicon Valley giants hope to increase their presence in medical services. The latest company to enter the field is Apple Computers. In March, Apple announced the availability of ResearchKit, an open-source software framework that turns the iPhone into a research tool. Pathologists and clinical lab scientists have a stake in the healthcare big data trend, since more than 70 percent of the typical patient's permanent medical record consists of medical laboratory test data.
Lab-inventory management: Time to take stock
Nature
When Marilyn Goudreault received a request for plasmids stored in the repository of the laboratory she manages at the Lunenfeld–Tanenbaum Research Institute in Toronto, Canada, there was never any question whether she would honor it. Reagent sharing is typically a precondition of publication in peer-reviewed journals, and is fundamental to the scientific process. But first, Goudreault would have to find the plasmids — circular strings of DNA. In many labs, the task might have required a tortuous search through old notebooks, out-of-date spreadsheets and frost-encrusted freezer boxes.
Missed last week's issue? See which articles your colleagues read most.
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
